Matthew E. Gegg
Impact in
- Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments
- Physiology top 0.5%
- Lysosomal Storage Disorders Research
- Alzheimer's disease research and treatments
- Calcium signaling and nucleotide metabolism
Papers in
- Physiology 26
- Lysosomal Storage Disorders Research 22
- Nitric Oxide and Endothelin Effects 4
- Neurology 18
- Parkinson's Disease Mechanisms and Treatments 17
- Co-authors
- Anthony H.V. Schapira (30 shared papers)Jonathan M. Cooper (4 shared papers)Kai‐Yin Chau (8 shared papers)Jan‐Willem Taanman (4 shared papers)Simon Heales (6 shared papers)Manuel Rojo (1 shared paper)Joana Magalhães (4 shared papers)Nicholas Wood (2 shared papers)
- Journals
- Human Molecular Genetics (6 papers)Neurobiology of Disease (5 papers)Journal of Neurochemistry (3 papers)PLoS ONE (2 papers)Parkinson s Disease (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Matthew E. Gegg
43 papers receiving 4.0k citations
Matthew E. Gegg's Hit Papers
Peers
Comparison fields: 5 of 108
- Neurology 1.7k
- Physiology 1.8k
- Physiology 290
- Cell Biology 950
- Neurology 369
Countries citing papers authored by Matthew E. Gegg
This map shows the geographic impact of Matthew E. Gegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Gegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Gegg more than expected).
Fields of papers citing papers by Matthew E. Gegg
This network shows the impact of papers produced by Matthew E. Gegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Gegg. The network helps show where Matthew E. Gegg may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew E. Gegg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy Hit paper breakdown → | 2010 | 740 |
| 2 | 2012 | 450 | |
| 3 | 2013 | 275 | |
| 4 | 2014 | 257 | |
| 5 | 2015 | 220 | |
| 6 | 2016 | 185 | |
| 7 | 2009 | 159 | |
| 8 | 2003 | 135 | |
| 9 | 2016 | 124 | |
| 10 | 2015 | 121 | |
| 11 | 2016 | 118 | |
| 12 | 2011 | 116 | |
| 13 | 2018 | 95 | |
| 14 | 2009 | 86 | |
| 15 | 2011 | 84 | |
| 16 | 2015 | 82 | |
| 17 | 2018 | 80 | |
| 18 | 2011 | 79 | |
| 19 | 2015 | 64 | |
| 20 | 2008 | 64 |
About Matthew E. Gegg
Matthew E. Gegg is a scholar working on Physiology, Neurology, Molecular Biology, Cell Biology and Epidemiology, having authored 44 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (22 papers), Parkinson's Disease Mechanisms and Treatments (17 papers), Cellular transport and secretion (13 papers), Autophagy in Disease and Therapy (9 papers), Nitric Oxide and Endothelin Effects (4 papers), Sulfur Compounds in Biology (4 papers), Retinal Development and Disorders (3 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Neurology (1.7k citations), Physiology (1.8k citations), Physiology (290 citations), Cell Biology (950 citations) and Neurology (369 citations). Matthew E. Gegg has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Anthony H.V. Schapira, Jonathan M. Cooper, Kai‐Yin Chau, Jan‐Willem Taanman, Simon Heales, Manuel Rojo, Joana Magalhães, Nicholas Wood, John Hardy and Derek Burke. Their work appears in journals such as Human Molecular Genetics, Neurobiology of Disease, Journal of Neurochemistry, PLoS ONE and Parkinson s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.